I-Mab Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$37.45 | $2.98 B | -9.99 | 63 |
APLS
Apellis Pharmaceuticals, Inc. |
$18.12 | $2.28 B | -11.36 | 705 |
ASND
Ascendis Pharma A/S |
$158.29 | $9.47 B | -21.33 | 1017 |
BGNE
BeiGene, Ltd. |
$184.71 | $20.21 B | -22.55 | 10600 |
BPMC
Blueprint Medicines Corporation |
$82.10 | $5.25 B | -76.73 | 649 |
CGEM
Cullinan Oncology, Inc. |
$7.61 | $445.28 M | -2.74 | 111 |
DSGN
Design Therapeutics, Inc. |
$3.39 | $192.43 M | -3.85 | 54 |
ERAS
Erasca, Inc. |
$1.18 | $332.84 M | -1.7 | 103 |
FHTX
Foghorn Therapeutics Inc. |
$3.49 | $194.09 M | -2.21 | 112 |
GLUE
Monte Rosa Therapeutics, Inc. |
$4.42 | $271.87 M | -4.51 | 134 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 |
IMVT
Immunovant, Inc. |
$14.85 | $2.52 B | -5.67 | 207 |
KRYS
Krystal Biotech, Inc. |
$164.70 | $4.74 B | 55.08 | 275 |
KYMR
Kymera Therapeutics, Inc. |
$25.04 | $1.63 B | -8.4 | 188 |
LYEL
Lyell Immunopharma, Inc. |
$0.45 | $133.17 M | -0.34 | 300 |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 |
NRIX
Nurix Therapeutics, Inc. |
$9.81 | $747.87 M | -3.52 | 286 |
RVMD
Revolution Medicines, Inc. |
$36.20 | $6.73 B | -10.11 | 534 |
STTK
Shattuck Labs, Inc. |
$0.76 | $36.60 M | -0.51 | 44 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
